Early research (Phase 1)Study completedNCT00882180
What this trial is testing
Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement
Who this might be right for
Solid Tumors
Alnylam Pharmaceuticals 41